55 related articles for article (PubMed ID: 25713761)
1. Prognostic significance of tumour stroma ratio in inflammatory breast cancer.
Downey CL; Thygesen HH; Sharma N; Shaaban AM
Springerplus; 2015; 4():68. PubMed ID: 25713761
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
EBioMedicine; 2024 May; 104():105152. PubMed ID: 38728838
[TBL] [Abstract][Full Text] [Related]
3. Tumour-stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJ; Backes Y; Elias SG; Seerden TC; Schwartz MP; Spanier BW; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JM; Groen JN; Ter Borg F; Wolfhagen FH; Seldenrijk CA; Raicu MG; Milne AN; van Lent AU; Brosens LA; Offerhaus GJA; Siersema PD; Tollenaar RA; Hardwick JC; Hawinkels LJ; Moons LM; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2020 Nov; 9(4):2050640620975324. PubMed ID: 33210982
[TBL] [Abstract][Full Text] [Related]
4. Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression.
Nastały P; Smentoch J; Popęda M; Martini E; Maiuri P; Żaczek AJ; Sowa M; Matuszewski M; Szade J; Kalinowski L; Niemira M; Brandt B; Eltze E; Semjonow A; Bednarz-Knoll N
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834440
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research.
Rea D; Francis A; Hanby AM; Speirs V; Rakha E; Shaaban A; Chan S; Vinnicombe S; Ellis IO; Martin SG; Jones LJ; Berditchevski F;
Br J Cancer; 2015 Apr; 112(9):1613-5. PubMed ID: 25867266
[No Abstract] [Full Text] [Related]
6. Lymph node status in inflammatory breast cancer.
Wecsler JS; Tereffe W; Pedersen RC; Sieffert MR; Mack WJ; Cui H; Russell CA; Woods RR; Viscusi RK; Sener SF; Lang JE
Breast Cancer Res Treat; 2015 May; 151(1):113-20. PubMed ID: 25846421
[TBL] [Abstract][Full Text] [Related]
7. Deep learning based tumor-stroma ratio scoring in colon cancer correlates with microscopic assessment.
Smit MA; Ciompi F; Bokhorst JM; van Pelt GW; Geessink OGF; Putter H; Tollenaar RAEM; van Krieken JHJM; Mesker WE; van der Laak JAWM
J Pathol Inform; 2023; 14():100191. PubMed ID: 36794267
[TBL] [Abstract][Full Text] [Related]
8. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review.
Morais EF; Morais HG; Martins HD; Carlan LM; Costa AD; Freitas RD
Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e301-e309. PubMed ID: 35717622
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer.
Forsare C; Vistrand S; Ehinger A; Lövgren K; Rydén L; Fernö M; Narbe U
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205688
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Efficacy of Tumor-Stroma Ratio in Women With Breast Cancer: A Meta-Analysis of Cohort Studies.
Jiang P; Chen Y; Liu B
Front Oncol; 2021; 11():731409. PubMed ID: 34976792
[TBL] [Abstract][Full Text] [Related]
12. Toward a quantitative method for estimating tumour-stroma ratio in breast cancer using polarized light microscopy.
Sprenger J; Murray C; Lad J; Jones B; Thomas G; Nofech-Mozes S; Khorasani M; Vitkin A
Biomed Opt Express; 2021 Jun; 12(6):3241-3252. PubMed ID: 34221657
[TBL] [Abstract][Full Text] [Related]
13. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
[No Abstract] [Full Text] [Related]
14. Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
Millar EK; Browne LH; Beretov J; Lee K; Lynch J; Swarbrick A; Graham PH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322174
[TBL] [Abstract][Full Text] [Related]
15. Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling.
Yang T; Zhiheng H; Zhanhuai W; Qian X; Yue L; Xiaoxu G; Jingsun W; Shu Z; Kefeng D
Front Oncol; 2020; 10():1747. PubMed ID: 33072555
[TBL] [Abstract][Full Text] [Related]
16. Novel quantitative signature of tumor stromal architecture: polarized light imaging differentiates between myxoid and sclerotic human breast cancer stroma.
Jones B; Thomas G; Westreich J; Nofech-Mozes S; Vitkin A; Khorasani M
Biomed Opt Express; 2020 Jun; 11(6):3246-3262. PubMed ID: 32637252
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the Tumor-Stromal Ratio in Invasive Breast Cancer and a Proposal of a New Ts-TNM Staging System.
Xu Q; Yuan JP; Chen YY; Zhang HY; Wang LW; Xiong B
J Oncol; 2020; 2020():9050631. PubMed ID: 32377197
[TBL] [Abstract][Full Text] [Related]
18. The intra-tumoural stroma in patients with breast cancer increases with age.
Vangangelt KMH; Kramer CJH; Bastiaannet E; Putter H; Cohen D; van Pelt GW; Rakha EA; Green AR; Tollenaar RAEM; Mesker WE
Breast Cancer Res Treat; 2020 Jan; 179(1):37-45. PubMed ID: 31535319
[TBL] [Abstract][Full Text] [Related]
19. Novel methodology to image stromal tissue and assess its morphological features with polarized light: towards a tumour microenvironment prognostic signature.
Westreich J; Khorasani M; Jones B; Demidov V; Nofech-Mozes S; Vitkin A
Biomed Opt Express; 2019 Aug; 10(8):3963-3973. PubMed ID: 31452988
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.
Kramer CJH; Vangangelt KMH; van Pelt GW; Dekker TJA; Tollenaar RAEM; Mesker WE
Breast Cancer Res Treat; 2019 Jan; 173(1):55-64. PubMed ID: 30302588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
